Advertisement
Research Article

The Effect of Azithromycin on Ivermectin Pharmacokinetics—A Population Pharmacokinetic Model Analysis

  • Ahmed El-Tahtawy mail,

    ahmed.el-tahtawy@pfizer.com

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    X
  • Paul Glue,

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    X
  • Emma N. Andrews,

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    X
  • Jack Mardekian,

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    X
  • Guy W. Amsden,

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    ¤ Current address: Clinical Research Division, Bassett Healthcare Research Institute, Bassett Healthcare, Cooperstown, New York, United States of America

    X
  • Charles A. Knirsch

    Affiliation: Global Clinical Research, Pfizer, New York, New York, United States of America

    X
  • Published: May 14, 2008
  • DOI: 10.1371/journal.pntd.0000236

About the Authors

Ahmed El-Tahtawy, Paul Glue, Emma N. Andrews, Jack Mardekian, Guy W. Amsden, Charles A. Knirsch
Global Clinical Research, Pfizer, New York, New York, United States of America

Corresponding Author

Email: ahmed.el-tahtawy@pfizer.com

Competing Interests

GWA is a consultant for Pliva and has done antimicrobial research for Pfizer, Abbott, Aventis, Bayer, GlaxoSmithKline, and Bristol-Myers Squibb. All other authors are employees of Pfizer, Inc., who sponsored this analysis.

Author Contributions

Conceived and designed the experiments: AE-T PG EA JM GA CK. Performed the experiments: AE-T PG. Analyzed the data: AE-T PG EA JM GA CK. Contributed reagents/materials/analysis tools: AE-T PG. Wrote the paper: AE-T PG EA JM GA CK.